Company profile
AGCT researches, develops and commercializes genome editing techniques for the cure of socially significant diseases.
Capital profile
No public funding data is available for this company.
No public relation records are available.
Preview only. Contact details are available after you sign in.
Log in to view people and contact details at this companyContact information and company affiliations may no longer be accurate. Verify details before reaching out.
Shipment data
Sign in to view shipment history, products, suppliers, and trade lanes for this company.
Log in to view shipment dataShipment records and coverage can change as the dataset is updated.
